Role of L-arginine/NO/cGMP/KATP channel signaling pathway in the central and peripheral antinociceptive effect of thymoquinone in rats
Open Access
- 1 June 2018
- journal article
- research article
- Vol. 21 (6) , 625-633
Abstract
Objective(s): Growing evidence demonstrates that L-arginine/NO/cGMP/K-ATP channel pathway has a modulatory role in pain perception. Previous studies have shown that thymoquinone exerts antinociceptive effects; however, the mechanisms underlying antinociception induced by thymoquinone have not been fully clarified. The aim of the present study was to evaluate the role of L-arginine/NO/cGMP/K-ATP channel pathway in the central and peripheral antinociceptive effect of thymoquinone in rats. Materials and Methods: Rats were pretreated intraplantarly (IPL) or intracerebroventricularly (ICV) with L-arginine (the NO precursor), l-NAME (an NO synthase inhibitor), SNAP (an NO donor), methylene blue (a guanylyl cyclase inhibitor), glibenclamide (the blocker of K-ATP channel), and tetraethylammonium (TEA, a K-v channel blocker) before the injection of thymoquinone. Results: Local ipsilateral (20 and 40 mu g, IPL) but not contralateral and ICV (4 and 8 mu g) administration of thymoquinone caused a dose-dependent and significant antinociception in both early and late phases of the formalin test. Pretreatment of rats with L-arginine (100 mu g, IPL or ICV) and SNAP (200 mu g, IPL or ICV) increased while l-NAME (100 mu g, IPL or 1 mu g, ICV) and methylene blue (400 mu g, IPL or ICV) decreased the antinociceptive effects of thymoquinone in the formalin test. The administration of TEA (IPL or ICV) did not modify but glibenclamide (50 mu g, IPL or ICV) significantly abolished the peripheral and central antinociceptive effects of thymoquinone in both phases of the formalin test. Conclusion: The results of the present study indicate that L-arginine/NO/cGMP/K-ATP channel pathway participates in the central and peripheral antinociceptive effect of thymoquinone.Keywords
This publication has 44 references indexed in Scilit:
- Nitric oxide signaling via cGMP‐stimulated phosphodiesterase in striatal neuronsSynapse, 2010
- Nitric oxide and pain: ‘Something old, something new’Acta Anaesthesiologica Scandinavica, 2009
- Role of nitric oxide/cyclic GMP/K+ channel pathways in the antinociceptive effect caused by 2,3-bis(mesitylseleno)propenolLife Sciences, 2007
- Possible activation of the NO–cyclic GMP–protein kinase G–K+ channels pathway by gabapentin on the formalin testPharmacology Biochemistry and Behavior, 2006
- The involvement of nitric oxide on the analgesic effect of tramadolEuropean Journal of Anaesthesiology, 2006
- Involvement of potassium channels and nitric oxide in tramadol antinociceptionPharmacology Biochemistry and Behavior, 2005
- Diclofenac-induced peripheral antinociception is associated with ATP-sensitive K+ channels activationLife Sciences, 2004
- The NO–cGMP–K+ channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacinPharmacology Biochemistry and Behavior, 2003
- The peripheral antinociceptive effect induced by morphine is associated with ATP‐sensitive K+ channelsBritish Journal of Pharmacology, 2000
- Antinociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opioidergic systemsEuropean Journal of Pharmacology, 1992